The cytotoxic function of CAR-T cells targeted to EGFR against hypopharyngeal squamous cell carcinoma was verified as well in a preclinical study conducted by a team which had already successfully built and verified EGFR-CAR-T-cells (19). This evidence concerns the gene EGFR and hypopharynx squamous cell carcinoma.